How do I integrate CHRS logo into my trading app?

Simply embed the API URL as an image source in your application. For example: . The API returns optimized images with proper caching headers for fast loading.

Coherus Oncology, Inc. (CHRS) Logo

Q: How do I get the Coherus Oncology, Inc. (CHRS) logo via API?

Use our Stock Logo API with the ticker symbol CHRS. Make a GET request to https://api.logostream.dev/stocks/symbol/CHRS?key=YOUR_API_KEY to receive the logo. You can also specify format (SVG, PNG, WebP) and size parameters.

Q: What formats are available for CHRS logo?

The Coherus Oncology, Inc. (CHRS) logo is available in SVG, PNG, WebP, and JPG formats. SVG is recommended for scalability. Use the format parameter to specify your preferred format, e.g., ?format=svg or ?format=png.

Q: Can I use the Coherus Oncology, Inc. (CHRS) logo commercially?

With a logostream API subscription, you can use logos for display purposes in financial applications, trading platforms, dashboards, and portfolio trackers. The logos are provided for informational and display purposes within your application.

Coherus Oncology, Inc. (CHRS) symbol, logo with name and high resolution download options.

Download Logo Stock API

Sector

Healthcare

Industry

Biotechnology

Ticker

CHRS

Website

coherus.com

About Coherus Oncology, Inc. (CHRS)

Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin 27. It also develops CHS-114, an investigational highly specific human afucosylated IgG1 monoclonal antibody, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME); and CHS-1000, Anti-ILT4 monoclonal antibody for solid tumors. In addition, the company offers GSK4381562, an antibody targeting CD112R to treat tumor cells; YUSIMRY, a biosimilar to Humira for inflammatory diseases characterized by increased production of tumor necrosis factor (TNF) in the body, such as rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohnâs disease, psoriasis, and ulcerative colitis; and CIMERLI, a Lucentis biosimilar to treat neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization. It has a collaboration agreement with Junshi Biosciences for the co-development and commercialization of toripalimab; agreement with Surface and Adimab LLC; license agreements with Bioeq AG and Genentech, Inc. and Surface and Vaccinex, Inc.; and out-licensing agreement with Novartis Institutes for Biomedical Research, Inc. and GlaxoSmithKline Intellectual Property No. 4 Limited. The company was formerly known as Coherus BioSciences, Inc. and changed its name to Coherus Oncology, Inc. in May 2025. The company was incorporated in 2010 and is based in Redwood City, California.

ISIN: US19249H1032

Ticker: 8C5

Ticker: 8C5.DU

Ticker: 8C5.F

Ticker: 8C5.MU

Ticker: 8C5.SW

Ticker: A12ETZ

Ticker: CHRS

Get Coherus Oncology, Inc. (CHRS) Logo via API

Integrate this logo into your application with a single API call

GET https://api.logostream.dev/stocks/symbol/CHRS?key=YOUR_API_KEY&variant=icon

View Full Documentation

Why Use Our Stock Logo API?

Fast Delivery

<100ms response time via global CDN

Enterprise-Ready

99.99% uptime SLA with GDPR compliance

Multiple Formats

SVG, PNG, WebP - scalable to any size

400k+ Logos

Stocks, ETFs, Crypto, Banks, and more

Where to Use Stock Logos

Trading Platforms

Real-time stock displays with instant logo loading

Portfolio Apps

Visualize holdings with recognizable brand logos

Financial Dashboards

Enhance market data with company branding

News & Research

Illustrate articles with accurate company logos

Frequently Asked Questions

Use our Stock Logo API with the ticker symbol CHRS. Make a GET request to https://api.logostream.dev/stocks/symbol/CHRS?key=YOUR_API_KEY to receive the logo. You can also specify format (SVG, PNG, WebP) and size parameters.

The Coherus Oncology, Inc. (CHRS) logo is available in SVG, PNG, WebP, and JPG formats. SVG is recommended for scalability. Use the format parameter to specify your preferred format, e.g., ?format=svg or ?format=png.

With a logostream API subscription, you can use logos for display purposes in financial applications, trading platforms, dashboards, and portfolio trackers. The logos are provided for informational and display purposes within your application.

Simply embed the API URL as an image source in your application. For example: <img src="https://api.logostream.dev/stocks/symbol/CHRS?key=YOUR_API_KEY" />. The API returns optimized images with proper caching headers for fast loading.

Need Stock Logos for Your Application?

Access 380,000+ company logos via our simple REST API. Perfect for trading platforms, portfolio apps, and financial dashboards.

View Documentation Request API Key